Screener
Neumora Therapeutics, Inc. NMRA Q3 2025 earnings
Reported November 6, 2025 · Before market open
EPS-$0.35Miss by $0.01
EPS estimate-$0.34
Next report
Nov 5, 2026 (in 2 months)EPS estimate-$0.19
Versus estimates
Diluted EPS
FAQ
- When did Neumora Therapeutics, Inc. report Q3 2025 earnings?
- Neumora Therapeutics, Inc. (NMRA) reported Q3 2025 earnings on November 6, 2025 before market open.
- What were Neumora Therapeutics, Inc.'s Q3 2025 revenue and EPS?
- Neumora Therapeutics, Inc. reported eps of $-0.35 for Q3 2025.
- Did Neumora Therapeutics, Inc. beat estimates in Q3 2025?
- EPS missed the consensus estimate of $-0.34 by $0.01.
- How did Neumora Therapeutics, Inc.'s Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 22.2% from $-0.45.
- Where can I find Neumora Therapeutics, Inc.'s Q3 2025 SEC filings?
- You can read the 8-K earnings release (0001193125-25-268046) and the 10-Q periodic report (0001193125-25-269446) directly on SEC EDGAR. The filing index links above go to sec.gov.
